article thumbnail

Ichnos Glenmark Innovation presents first clinical data from phase 1 study of Trispecific TREAT Antibody, ISB 2001

Express Pharma

Professor of Haematology, University of Melbourne and Director of Haematology, St Vincents Hospital Melbourne. The post Ichnos Glenmark Innovation presents first clinical data from phase 1 study of Trispecific TREAT Antibody, ISB 2001 appeared first on Express Pharma.

article thumbnail

Episode 890: How to Succeed at Journal Club Without Really Trying

Pharmacy Joe

For example, if the new article is about glucose control in the ICU, you can be sure that the letter to the editor will mention other landmark trials such as 2001 article by Van Den Berghe and NICE-SUGAR.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Bridging the healthcare digital divide: a gradual approach to adopting ePI

European Pharmaceutical Review

A gradual approach and education Recognising the potential challenges and burdens that a complete shift to ePI might pose, there is support for a gradual implementation, especially in hospital settings and for products administered by healthcare professionals. References European Commission, (26 April 2023). Article 63 EMA (29 January 2020).

article thumbnail

5 Ways Your Pharmacy Can Participate in National Pain Awareness Month

Digital Pharmacist

National Pain Awareness Month was established in 2001 by numerous organizations working together in conjunction with the American Chronic Pain Association. By holding an informative program at your hospital, community center, library, or pharmacy, a pharmacy may empower and inspire the community. What is National Pain Awareness Month?

article thumbnail

The Use of Thrombolytics for ACS

Pharmacy Friday Pearls

2001; 286(4): 442-449. Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. Longterm survival and neurological outcome of patients who received recombinant tissue plasminogen activator during out-of-hospital cardiac arrest. in tenecteplase vs 5.8%

article thumbnail

Episode 890: How to Succeed at Journal Club Without Really Trying

Pharmacy Joe

For example, if the new article is about glucose control in the ICU, you can be sure that the letter to the editor will mention other landmark trials such as 2001 article by Van Den Berghe and NICE-SUGAR.

article thumbnail

Country focus: China & APAC’s growing medical needs bring opportunities and challenges

pharmaphorum

“Each market has its own nuances with respect to regulations governing the conduct of clinical trials, data requirements to support regulatory submissions, market access framework, hospital networks and therapeutic area competitiveness,” he adds. “It From 2006, Dr Mei worked as a senior director at Novartis Oncology.